Patent · US Active

Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide

US8895520B2 · kind B2 · utility

0Cited by

6References

7Claims

0Family size

Assignees

Université de Nice Sophia-Antipolis · FR
CENTRE HOSPITALIER ET UNIVERSITAIRE DE BREST · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Thomas Cluzeau · Nice, FR
Patrick Auberger · Nice, FR
Guillaume Robert · Kembs, FR

Key dates

Filing date	Oct 26, 2011
Grant date	Nov 25, 2014
Priority date	—
Expiry date	Dec 16, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treatment of a human patient suffering from myeloid neoplasias, includes administrating a therapeutically effective amount of 5-aminoimidazole-4-carboxamide (acadesine), acadesine precursors or acadesine derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.